GlassScriptPhysician profile
Garnet R Craddock
NPI 1588646012
$8,671.06
in general payments reported to CMS, 2019-2025
8 companies · $4,888 in 2025
The $4,888 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $198 · 2021: $206 · 2022: $84.61 · 2023: $211 · 2024: $2,877 · 2025: $4,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,533 · Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,533.33 |
| Food and Beverage | $443.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,554.33 | 2023-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Boston Scientific Corporation | $424.49 | 2020-2025 | Varithena Administration Pack |
| Tactile Systems Technology INC | $302.32 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Medtronic, INC. | $176.91 | 2021-2025 | Venaseal |
| Medtronic Vascular, INC. | $111.89 | 2019-2020 | |
| Allergan, INC. | $52.92 | 2019-2021 | |
| Medline Industries LP | $37.06 | 2024 | |
| Merz North America, INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garnet Craddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.